Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Episode 87 with Dr. Ellen Mowry on testing restricted calorie diets in MS
MS Research Roundup: March 21, 2014
MS Research Roundup: March 2, 2015
MS Research Roundup: July 9, 2014
Episode 90 with Dr. Daniel Hartung on pricing trends for MS disease-modifying therapies in the US
Episode 86 with Dr. Pavan Bhargava on targeting lesions lining the brain
ISNVD 2016 Conference
Genetic Marker May Underlie Sex Difference in MS Susceptibility
Toso: A New Drug Target for MS?
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.
Papers: 8 Apr 2013 - 15 Apr 2013
Fuel Injection
Episode 73 with Dr. Donna Osterhout on the dynamics of myelin-making cells
Kir4.1 Potassium Channels in MS: Discrepant Results From Two Studies
Abnormal Venous Outflow Dynamics May Not Be Implicated in MS
rhGH effect on remyelination
Cognitive Reserve in MS: Life Experiences Matter
Keystone Symposia Conference: Neuroinflammation in Diseases of the Central Nervous System
Immunophenotyping Separates MS Subtypes by Neuroinflammation
MS Research Roundup: 8 January 2016
FDA's Denial of Alemtuzumab Stirs Controversy
MS Research Roundup: February 20, 2014
Papers: 4 Jul 2014 - 11 Jul 2014
Low-Dose Naltrexone and Met-Enkephalin Improve EAE Mice
Episode 93 with Dr. Lilyana Amezcua on MS in the Hispanic community
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
